ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Thermo Fisher to double viral vector services with $180 million project

by Rick Mullin
May 15, 2020 | APPEARED IN VOLUME 98, ISSUE 19

 

Thermo Fisher Scientific will expand its viral vector services with the construction of a facility in Plainville, Massachusetts. The $180 million project will more than double Thermo Fisher’s capacity to serve developers of gene therapies and vaccines. The company expanded similar operations last year in Alachua, Florida. It also has viral vector operations in Lexington and Cambridge, Massachusetts. Thermo Fisher expects the 26,900 m2 facility in Plainville to be completed in 2022, adding more than 200 jobs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment